Figure 4.
Local and distant disease failures. Cumulative incidence of local and distant failures for patients treated for early-stage GML (N = 166), using death as a competing risk. Five-year and 10-year local failure rates were 3.9% and 8.3%, respectively, whereas 5-year and 10-year distant failure rates were 6.9% and 11%, respectively.